Skip to main content
. 2016 Dec 19;8(3):4289–4300. doi: 10.18632/oncotarget.14024

Table 4. The diagnostic accuracy of LivFib index for predicting significant fibrosis, advanced fibrosis and cirrhosis in retrospective cohort, prospective cohort and total cohort.

Cut-off values Positive
(n)
Negative
(n)
Sensitivity Specificity PPV# NPV# DCR#
Significant Fibrosis (Ishak: 0-2 vs. 3-6)
Retrospective Cohort >3.0 1902 71 91.2% 21.4% 96.4% 9.6% 88.3%
>4.0 1227 27 58.9% 70.0% 97.8% 6.9% 59.3%
>5.0 538 5 25.8% 94.3% 99.0% 5.2% 28.7%
Prospective Cohort >3.0 1447 68 90.4% 16.7% 95.5% 8.1% 86.8%
>4.0 920 27 57.5% 66.7% 97.1% 7.4% 57.9%
>5.0 405 6 25.3% 92.6% 98.5% 5.9% 28.6%
Total Cohort >3.0 446 8 93.0% 43.8% 98.3% 15.6% 91.6%
>4.0 296 3 61.6% 81.3% 99.1% 5.9% 62.1%
>5.0 125 4 26.3% 77.9% 96.9% 3.9% 28.1%
Advanced Fibrosis (Ishak: 0-3 vs. 4-6)
Retrospective Cohort >3.0 1717 258 93.6% 24.3% 86.9% 41.3% 82.7%
>4.0 1154 101 62.9% 70.3% 91.9% 26.1% 64.0%
>5.0 519 25 28.3% 92.8% 95.5% 19.4% 38.4%
Prospective Cohort >3.0 1242 322 94.3% 11.6% 79.4% 35.9% 76.4%
>4.0 864 83 61.7% 70.6% 91.3% 27.0% 63.2%
>5.0 390 21 27.8% 92.5% 94.9% 20.5% 38.7%
Total Cohort >3.0 404 51 94.6% 23.7% 88.8% 40.9% 85.0%
>4.0 278 20 65.1% 69.7% 93.2% 23.9% 65.7%
>5.0 124 4 29.1% 93.4% 96.6% 17.1% 37.9%
Cirrhosis (Ishak: 0-4 vs. 5-6)
Retrospective Cohort >3.0 1462 513 95.6% 20.7% 74.0% 66.5% 73.3%
>4.0 1039 215 67.9% 66.7% 82.8% 46.8% 67.6%
>5.0 485 58 31.7% 91.0% 89.3% 36.0% 49.3%
Prospective Cohort >3.0 1099 416 95.3% 21.4% 72.6% 67.6% 72.1%
>4.0 769 178 66.7% 66.4% 81.2% 47.7% 66.6%
>5.0 363 48 31.5% 90.9% 88.3% 37.8% 50.1%
Total Cohort >3.0 350 105 96.1% 19.0% 76.9% 63.6% 75.9%
>4.0 256 42 70.2% 67.3% 85.8% 44.6% 69.5%
>5.0 117 11 32.2% 91.2% 91.1% 32.4% 47.7%

# PPV, Positive Predictive Value; NPV, Negative Predictive Value; DCR, Diagnostic Coincidence Rate.